The Trump administration’s decision to exempt tariffs on Indian pharma imports brings relief to a $9 billion-plus US export market, highlighting India’s key role in providing affordable generic medicines. However, India’s medical device sector faces a 26% reciprocal tariff, potentially impacting its growth and exports. Post navigation Government exempted from open offer in Voda Idea Trump tariff: Dalal Street dodges drubbing on Day 1
